21-45486713-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001379500.1(COL18A1):c.1702-148C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 799,392 control chromosomes in the GnomAD database, including 19,379 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.19 ( 3012 hom., cov: 33)
Exomes 𝑓: 0.22 ( 16367 hom. )
Consequence
COL18A1
NM_001379500.1 intron
NM_001379500.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.135
Publications
20 publications found
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL18A1 Gene-Disease associations (from GenCC):
- Knobloch syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Knobloch syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet
- hereditary glaucoma, primary closed-angleInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 21-45486713-C-T is Benign according to our data. Variant chr21-45486713-C-T is described in ClinVar as Benign. ClinVar VariationId is 1287312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.231 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL18A1 | NM_001379500.1 | c.1702-148C>T | intron_variant | Intron 15 of 41 | ENST00000651438.1 | NP_001366429.1 | ||
| COL18A1 | NM_130444.3 | c.2947-148C>T | intron_variant | Intron 14 of 40 | NP_569711.2 | |||
| COL18A1 | NM_030582.4 | c.2242-148C>T | intron_variant | Intron 14 of 40 | NP_085059.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL18A1 | ENST00000651438.1 | c.1702-148C>T | intron_variant | Intron 15 of 41 | NM_001379500.1 | ENSP00000498485.1 | ||||
| COL18A1 | ENST00000355480.10 | c.2242-148C>T | intron_variant | Intron 14 of 40 | 1 | ENSP00000347665.5 | ||||
| COL18A1 | ENST00000359759.8 | c.2947-148C>T | intron_variant | Intron 14 of 40 | 5 | ENSP00000352798.4 |
Frequencies
GnomAD3 genomes AF: 0.193 AC: 29438AN: 152154Hom.: 3012 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
29438
AN:
152154
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.221 AC: 142731AN: 647120Hom.: 16367 AF XY: 0.219 AC XY: 73063AN XY: 333788 show subpopulations
GnomAD4 exome
AF:
AC:
142731
AN:
647120
Hom.:
AF XY:
AC XY:
73063
AN XY:
333788
show subpopulations
African (AFR)
AF:
AC:
1696
AN:
15080
American (AMR)
AF:
AC:
4456
AN:
20678
Ashkenazi Jewish (ASJ)
AF:
AC:
4075
AN:
15490
East Asian (EAS)
AF:
AC:
3335
AN:
29838
South Asian (SAS)
AF:
AC:
9301
AN:
52348
European-Finnish (FIN)
AF:
AC:
5956
AN:
30324
Middle Eastern (MID)
AF:
AC:
695
AN:
2612
European-Non Finnish (NFE)
AF:
AC:
106260
AN:
448404
Other (OTH)
AF:
AC:
6957
AN:
32346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
5074
10147
15221
20294
25368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2284
4568
6852
9136
11420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.193 AC: 29435AN: 152272Hom.: 3012 Cov.: 33 AF XY: 0.193 AC XY: 14403AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
29435
AN:
152272
Hom.:
Cov.:
33
AF XY:
AC XY:
14403
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
4763
AN:
41566
American (AMR)
AF:
AC:
3438
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
890
AN:
3472
East Asian (EAS)
AF:
AC:
712
AN:
5178
South Asian (SAS)
AF:
AC:
882
AN:
4834
European-Finnish (FIN)
AF:
AC:
2197
AN:
10610
Middle Eastern (MID)
AF:
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15934
AN:
67990
Other (OTH)
AF:
AC:
456
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1271
2542
3812
5083
6354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
328
656
984
1312
1640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
599
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.